GO:0014722 regulation of skeletal muscle contraction by calcium ion signaling: Calcium Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0014722 describes how calcium ion signals modulate the frequency, rate, or extent of skeletal muscle contraction.
• Calcium release from the sarcoplasmic reticulum through ryanodine receptor 1 (RYR1) is the primary trigger for skeletal muscle contraction.
• The sarcoplasmic reticulum Ca2+-ATPase (SERCA) pumps calcium back into the SR to terminate contraction and enable relaxation.
• Dysregulation of calcium signaling in skeletal muscle contributes to atrophy, fatigue, and metabolic myopathies.
• Key proteins include RYR1, CACNA1S, ATP2A1, CASQ1, and CALM1, which coordinate excitation-contraction coupling.
• CRISPR-based models (knockout, point mutation, knock-in) are essential to dissect causal roles of calcium-handling genes in muscle physiology.
Description
The Gene Ontology term GO:0014722, regulation of skeletal muscle contraction by calcium ion signaling, defines any process that modulates the frequency, rate, or extent of skeletal muscle contraction by changing the calcium ion signals that trigger contraction. Skeletal muscle contraction is initiated by action potentials that travel along the sarcolemma and transverse tubules, leading to calcium release from the sarcoplasmic reticulum (SR) via ryanodine receptor 1 (RYR1). This calcium signal activates the contractile machinery, and its precise regulation is critical for normal muscle function. Researchers study this process to understand muscle physiology, fatigue, and diseases such as malignant hyperthermia and Brody myopathy. The interplay between calcium influx, SR release, and reuptake determines contraction strength and duration.
regulation of skeletal muscle contraction by calcium ion signaling At A Glance
| GO ID | GO:0014722 |
|---|---|
| GO term | regulation of skeletal muscle contraction by calcium ion signaling |
| Ontology | biological_process |
| Synonym | regulation of skeletal muscle contraction by calcium ion signalling |
| Major function | Modulates skeletal muscle contraction by changing calcium ion signals that trigger contraction |
| Related cellular component | Sarcoplasmic reticulum, transverse tubules, sarcolemma |
| Key molecular players | RYR1, CACNA1S, ATP2A1, CASQ1, CALM1 |
| Associated diseases | Malignant hyperthermia, Brody myopathy, central core disease |
What Is GO:0014722?
GO:0014722 is a biological process that encompasses any mechanism which adjusts the frequency, rate, or extent of skeletal muscle contraction by altering the calcium ion signals that trigger contraction. This includes modulation of calcium release from intracellular stores, calcium reuptake, and calcium-dependent signaling pathways that ultimately control muscle shortening.
Why Is regulation of skeletal muscle contraction by calcium ion signaling Important in Cell Biology?
Understanding GO:0014722 is fundamental to muscle biology because calcium signaling is the central switch for contraction and relaxation. Defects in calcium handling proteins cause severe muscle disorders, including malignant hyperthermia, central core disease, and Brody myopathy. Moreover, calcium dysregulation contributes to muscle atrophy and weakness in aging and chronic diseases. Studying this process also informs therapeutic strategies targeting calcium channels and pumps in skeletal muscle.
• Calcium signaling is the primary trigger for skeletal muscle contraction.
• RYR1-mediated calcium release is essential for excitation-contraction coupling.
• SERCA pumps terminate contraction by removing calcium from the cytoplasm.
• Mutations in RYR1 cause malignant hyperthermia and central core disease.
• Calcium leak from SR contributes to muscle weakness and atrophy.
• Calcium signaling modulates muscle fatigue and adaptation to exercise.
• The process is a target for drugs treating muscle spasticity and myopathies.
• CRISPR screens can identify novel regulators of calcium homeostasis in muscle.
What Happens During regulation of skeletal muscle contraction by calcium ion signaling?
Excitation-contraction coupling and calcium release
In simple terms: When a nerve signals a muscle to move, an electrical impulse travels deep into the muscle cell and opens a channel that releases stored calcium.
Upon arrival of an action potential at the transverse tubules, the voltage-sensing dihydropyridine receptor (DHPR, CACNA1S) undergoes a conformational change that mechanically activates ryanodine receptor 1 (RYR1) on the sarcoplasmic reticulum (SR). This leads to a massive release of calcium ions from the SR into the cytoplasm, raising intracellular calcium concentration from ~100 nM to ~1-10 µM. The calcium then binds to troponin C, causing tropomyosin to shift and exposing myosin-binding sites on actin, which initiates cross-bridge cycling and muscle contraction.
Calcium reuptake and muscle relaxation
In simple terms: After the signal, calcium is pumped back into storage, allowing the muscle to relax.
Relaxation occurs when calcium is actively transported back into the SR by the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA, ATP2A1). SERCA activity is regulated by phospholamban (PLN) and sarcolipin (SLN), which modulate its calcium affinity. This reuptake lowers cytoplasmic calcium, causing calcium to dissociate from troponin C and allowing the muscle to relax.
Calcium buffering and storage
In simple terms: Calcium is stored in the muscle cell bound to proteins that keep it ready for release.
Inside the SR, calcium is buffered by calsequestrin (CASQ1) and other calcium-binding proteins, which allow high concentrations of calcium to be stored without precipitation. Calmodulin (CALM1) also modulates calcium signals by binding calcium and regulating downstream targets such as calcineurin and CaMKII.
Modulation by signaling pathways
In simple terms: Other signals can turn the calcium switch up or down, changing how strongly a muscle contracts.
Calcium signaling in skeletal muscle is modulated by beta-adrenergic stimulation, which enhances SERCA activity via phospholamban phosphorylation. Redox modifications of calcium channels and pumps also regulate calcium flux. Additionally, ATP availability tightly controls calcium pump function, as SERCA consumes ATP.
Key Genes Involved in GO:0014722 regulation of skeletal muscle contraction by calcium ion signaling
The following genes encode proteins that directly participate in or regulate calcium ion signaling during skeletal muscle contraction.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RYR1 | Calcium release channel of the sarcoplasmic reticulum | Mutations cause malignant hyperthermia and central core disease |
| CACNA1S | Voltage-sensor in transverse tubules that activates RYR1 | Target for malignant hyperthermia and periodic paralysis |
| ATP2A1 | SERCA1 calcium pump that reuptakes calcium into SR | Defects cause Brody myopathy |
| CASQ1 | Calcium-binding protein in SR lumen | Buffers calcium for rapid release |
| CALM1 | Calmodulin, calcium sensor | Regulates CaMKII and calcineurin signaling |
| PLN | Phospholamban, inhibits SERCA | Modulates relaxation rate |
| SLN | Sarcolipin, regulates SERCA | Influences thermogenesis and calcium handling |
| TRDN | Triadin, anchors CASQ1 to RYR1 | Mutations linked to arrhythmias and myopathy |
| JPH1 | Junctophilin-1, maintains T-tubule/SR junctions | Essential for excitation-contraction coupling |
| JPH2 | Junctophilin-2, stabilizes junctions | Implicated in cardiomyopathy and muscle weakness |
| STIM1 | Calcium sensor in SR/ER | Activates store-operated calcium entry |
| ORAI1 | Store-operated calcium channel | Modulates calcium refilling |
| TRPC1 | Stretch-activated calcium channel | Contributes to calcium influx in muscle |
| CAV3 | Caveolin-3, scaffolding protein | Mutations cause limb-girdle muscular dystrophy |
| BIN1 | Bridging integrator 1, T-tubule formation | Defects cause centronuclear myopathy |
| MTM1 | Myotubularin, phosphoinositide phosphatase | Mutations cause X-linked myotubular myopathy |
| DNM2 | Dynamin 2, membrane remodeling | Linked to centronuclear myopathy |
| ATP2B1 | Plasma membrane calcium ATPase | Extrudes calcium to maintain homeostasis |
How Is regulation of skeletal muscle contraction by calcium ion signaling Regulated?
The process of regulation of skeletal muscle contraction by calcium ion signaling is itself regulated at multiple levels. Beta-adrenergic signaling enhances SERCA activity through phosphorylation of phospholamban, thereby accelerating relaxation. Redox modifications of RYR1 and SERCA can alter calcium flux. ATP levels directly influence SERCA pump activity, linking metabolic state to calcium handling. Additionally, calcium-binding proteins such as calmodulin and calcineurin decode calcium signals into downstream transcriptional responses.
regulation of skeletal muscle contraction by calcium ion signaling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RYR1 | Malignant hyperthermia, central core disease | Knock-in mouse with RYR1 mutation |
| ATP2A1 | Brody myopathy | Knockout of ATP2A1 in C2C12 myotubes |
| CASQ1 | Vacuolar myopathy | CASQ1 knockout mouse |
| CACNA1S | Hypokalemic periodic paralysis | Point mutation knock-in mouse |
| PLN | Cardiomyopathy and muscle weakness | Overexpression of PLN in skeletal muscle |
Malignant hyperthermia and central core disease
Mutations in RYR1 lead to uncontrolled calcium release from the SR, causing malignant hyperthermia in response to anesthetics and central core disease, a congenital myopathy. These conditions highlight the critical role of tight calcium regulation in muscle function.
Brody myopathy
Brody myopathy is caused by mutations in ATP2A1, the gene encoding SERCA1, resulting in impaired calcium reuptake and delayed muscle relaxation. Patients experience exercise-induced muscle stiffness and cramps.
Muscle atrophy and weakness
Dysregulation of calcium homeostasis, including increased SR calcium leak, contributes to muscle atrophy and weakness in aging and chronic diseases such as heart failure and cancer cachexia. Targeting calcium leak channels is a potential therapeutic strategy.
From regulation of skeletal muscle contraction by calcium ion signaling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RYR1 function abolish calcium release? | RYR1 knockout in C2C12 myotubes |
| Does a specific RYR1 mutation cause calcium leak? | Point mutation knock-in (e.g., RYR1 R163C) in mice |
| Can a calcium sensor be tagged to track SR calcium? | Knock-in of genetically encoded calcium indicator (GCaMP) into RYR1 locus |
| Does overexpression of SERCA improve relaxation? | Overexpression of ATP2A1 in skeletal muscle |
| What genes regulate calcium homeostasis in muscle? | CRISPR library screening in muscle cells |
| Does a disease-associated variant affect calcium signaling? | Knock-in of patient variant in mouse model |
How to Study the regulation of skeletal muscle contraction by calcium ion signaling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium imaging (Fura-2, GCaMP) | Intracellular calcium concentration dynamics | Measuring calcium transients in myotubes |
| Patch-clamp | Ion channel currents | Recording L-type calcium currents in muscle fibers |
| CRISPR knockout screening | Gene function on calcium signaling | Identifying novel regulators of contraction |
| RNA-seq | Transcriptional changes | Profiling gene expression in muscle atrophy |
| Proteomics | Protein abundance and modifications | Quantifying SERCA and RYR1 levels |
| FRET-based sensors | Real-time calcium and ATP levels | Monitoring excitation-contraction coupling |
| Electron microscopy | Ultrastructure of SR and T-tubules | Assessing junctional integrity |
| Contractility assays | Force generation | Measuring muscle function in vitro |
Calcium imaging
Fluorescent calcium indicators such as Fura-2 or GCaMP are used to measure intracellular calcium transients in isolated muscle fibers or myotubes. This method reveals the kinetics of calcium release and reuptake.
Patch-clamp electrophysiology
Patch-clamp techniques measure calcium currents through voltage-gated channels and the activity of calcium-activated channels in the sarcolemma. This provides direct insight into excitation-contraction coupling.
CRISPR screening
Genome-wide CRISPR knockout or activation screens in muscle cell lines can identify novel regulators of calcium signaling and muscle contraction. Hits are validated by calcium imaging and contractility assays.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify changes in calcium-handling proteins and their post-translational modifications in response to exercise or disease.
How CRISPR Can Be Used to Study GO:0014722 regulation of skeletal muscle contraction by calcium ion signaling
Knockout
CRISPR knockout of genes such as RYR1 or ATP2A1 in muscle cell lines or animal models can abolish calcium release or reuptake, providing causal evidence for their role in contraction. Knockout models are essential to study loss-of-function phenotypes.
Point Mutation
Introducing disease-associated point mutations (e.g., RYR1 R163C) via CRISPR base editing or HDR recreates malignant hyperthermia susceptibility in cells and mice, allowing precise dissection of calcium leak mechanisms.
Knock-in
Knock-in of genetically encoded calcium indicators (GCaMP) or tags into endogenous loci enables real-time monitoring of calcium signals in native muscle tissue. This approach preserves physiological expression levels.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of SERCA (ATP2A1) can enhance calcium reuptake and improve muscle relaxation, offering therapeutic insights for Brody myopathy.
How EDITGENE Supports regulation of skeletal muscle contraction by calcium ion signaling Research
Researchers studying regulation of skeletal muscle contraction by calcium ion signaling-related genes often need to determine whether a candidate gene is causally involved in calcium handling and muscle function. EDITGENE provides comprehensive CRISPR-based services to create precise cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of skeletal muscle contraction by calcium ion signaling research.
Frequently Asked Questions About regulation of skeletal muscle contraction by calcium ion signaling
What is GO:0014722?
GO:0014722 is the Gene Ontology term for regulation of skeletal muscle contraction by calcium ion signaling, describing processes that modulate contraction by altering calcium signals.
What genes are involved in regulation of skeletal muscle contraction by calcium ion signaling?
Key genes include RYR1, CACNA1S, ATP2A1, CASQ1, and CALM1, which control calcium release, reuptake, and sensing.
How does calcium trigger skeletal muscle contraction?
Calcium released from the sarcoplasmic reticulum binds troponin C, moving tropomyosin to expose myosin-binding sites on actin, initiating cross-bridge cycling.
What diseases are linked to calcium signaling defects in skeletal muscle?
Mutations in RYR1 cause malignant hyperthermia and central core disease, while ATP2A1 mutations cause Brody myopathy.
What is the role of SERCA in muscle relaxation?
SERCA (ATP2A1) pumps calcium back into the sarcoplasmic reticulum, lowering cytoplasmic calcium and allowing muscle relaxation.
How can CRISPR be used to study calcium signaling in muscle?
CRISPR knockout, point mutation, and knock-in models can disrupt or modify genes like RYR1 and ATP2A1 to test their causal roles in calcium handling.
What methods measure calcium signals in muscle cells?
Calcium imaging with fluorescent indicators, patch-clamp electrophysiology, and FRET-based sensors are commonly used.
What is excitation-contraction coupling?
Excitation-contraction coupling is the process by which an action potential triggers calcium release from the SR, leading to muscle contraction.
Can calcium leak from the sarcoplasmic reticulum cause muscle weakness?
Yes, increased SR calcium leak contributes to muscle atrophy and weakness in aging and disease.
What model systems are used to study GO:0014722?
C2C12 myotubes, primary muscle fibers, and genetically modified mice are common models for studying calcium signaling in skeletal muscle.
Conclusion
GO:0014722 encompasses the critical calcium-dependent mechanisms that regulate skeletal muscle contraction. From RYR1-mediated calcium release to SERCA-driven reuptake, these processes are essential for normal muscle function and are implicated in severe myopathies. Continued research using CRISPR models and advanced imaging will unravel new therapeutic targets for muscle diseases.
References
- 1. Li X et al.. 2025. Regulation of calcium homeostasis in endoplasmic reticulum-mitochondria crosstalk: implications for skeletal muscle atrophy.. Cell Commun Signal 23(1):17 PMID: 39789595
- 4. Cheng H et al.. 2008. Calcium sparks.. Physiol Rev 88(4):1491-545 PMID: 18923188
- 5. Bovo E et al.. 2023. Regulation of cardiac calcium signaling by newly identified calcium pump modulators.. Biochem Biophys Res Commun 685:149136 PMID: 37907012
- 6. Kuo IY et al.. 2015. Signaling in muscle contraction.. Cold Spring Harb Perspect Biol 7(2):a006023 PMID: 25646377
- 7. Morad M et al.. 2000. Redox regulation of cardiac muscle calcium signaling.. Antioxid Redox Signal 2(1):65-71 PMID: 11232602
- 8. Rhana P et al.. 2024. Fueling the heartbeat: Dynamic regulation of intracellular ATP during excitation-contraction coupling in ventricular myocytes.. Proc Natl Acad Sci U S A 121(25):e2318535121 PMID: 38865270
